Detalhe da pesquisa
1.
A randomized, double-blind, non-inferiority trial comparing the immunogenicity and safety of two seasonal inactivated influenza vaccines in adults
Vaccine, v. 41, n. 22, 3454-3460, abr. 2023
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-4901
2.
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: a randomized, double-blind, placebo-controlled, phase 1 clinical trial
PloS One;
17(10): e0274943, 2022.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-4565
3.
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: a prospective cohort study of five target groups
PloS One, v. 16, n. 2, e0246540, fev. 2021
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-3536
4.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect Dis, v. 20, n. 7, p. 839-850, mar. 2020
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-2991
5.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect. Dis.;
2020.
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib17572